Aurobindo Pharma has said that it has received the US health administrator’s approval for Lopinavir/Ritonavir tablets used in the treatment of HIV infections. In a filing to the Bombay Stock Exchange, the pharma company said it has received approval from US Food and Drug Administration (USFDA) for tablets that are in the strength of 100/25 mg and 200/50 mg. Lopinavir/Ritonavir tablets are used in the treatment of HIV infection in adults and children above the age of two years, the filing added. Aurobindo now has a total of 93 abbreviated new drug application (ANDA) approvals from USFDA.
As Indians we know India in itself is an amazing nation and even the world agrees with that, however, grass is always greener on the other side and that is why Indians desire to immigrate a More
Helplinelaw can set up your session with quality and experienced lawyers to discuss and resolve your legal matters. You can avail consultation in form of sending questions, phone call or webchat discussion More